Oncol Lett 14: 6031-6039, 2017; DOI: 10.3892/ol.2017.6957
We have recently noticed an error in Fig. 2, which appeared in the above-mentioned article. Essentially, the y-axes of the plots showing the relative wound closure were printed inaccurately. The corrected version of Fig. 2 is shown below.
Figure 2.
Eupatolide inhibits the migration and invasion of breast cancer cells. (A) MDA-MB-231 and (B) MCF-7 cells were co-treated with either 100 ng/ml EGF or 50 ng/ml TGF-β1, as well as 10 μM eupatolide or a control, and the migration of cells was monitored for 24 h using an IncuCyte live-cell imaging system. After 24 h, relative wound density was acquired by IncuCyte. (C and D) MDA-MB-231 cells were seeded into Transwell chambers and stimulated with (C) 100 ng/ml EGF or (D) 50 ng/ml TGF-β1 independently, or were co-treated with 10 μM eupatolide. The number of invaded cells in the bottom chamber was counted to measure invasion levels. *P<0.05, **P<0.01. EGF, epidermal growth factor; TGF-β1, transforming growth factor-β1; EuTL, eupatolide.
We regret that this error occurred, and thank the Editor for allowing us the opportunity to publish this Corrigendum.